PositoAI/ US/ Annexon, Inc.

Annexon, Inc.

NasdaqGS: ANNX · Healthcare

Positivity Index

#4,555 / 6,774

Global

#2,307 / 4,000

United States

Positivity Score

19,287

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Annexon, Inc. — Overview & Financial Snapshot

Annexon, Inc. (NasdaqGS: ANNX) is a Healthcare company, ranked #4,555 of 6,774 companies globally and #2,307 of 4,000 in United States on PositoAI, with a Positivity Score of 19,287. Its market capitalisation is ₹6,817.82 Cr ($722.30M), P/E ratio is -3.4 and P/B ratio is 3.88. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. It is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.

P/B Ratio 3.88

P/E Ratio -3.4

D/E Ratio 0.13

ROE -105.26%

Owes vs Owns ? 0.24× Low $0.24 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-106.66$-1.13

Forward EPS ₹-101.31$-1.07

Beta 1.33

Market Cap ₹6,817.82 Cr$722.30M

What these numbers mean →

What does Annexon, Inc. do?

What is Annexon, Inc.'s P/E and P/B ratio?

Annexon, Inc. has a P/E ratio of -3.4 and a P/B ratio of 3.88.

What is Annexon, Inc.'s debt-to-equity ratio?

Annexon, Inc. has a debt-to-equity ratio of 0.13.

How much does Annexon, Inc. owe compared with what it owns?

Annexon, Inc. owes $0.24 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Annexon, Inc.'s Positivity rank?

Annexon, Inc. is ranked #4,555 of 6,774 companies globally and #2,307 of 4,000 in United States on PositoAI, with a Positivity Score of 19,287.

Does Annexon, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Annexon, Inc..

Where can I read the latest news about Annexon, Inc.?

Recent headlines about Annexon, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Annexon, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Annexon, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.